orthogonal thinker

Our platform approach allows shareholders to benefit from the revenues of multiple holdings and subsidiaries. We envision a future where “farmaceutical” products will usher in a new period of health and wellness based on psychoactive compounds and clean label products.

Recent News

Compounds

private company

TSX.V: NUMI

Focus